Results: 24

Genetic and phenotypic traits of children and adolescents with cystic fibrosis in Southern Brazil

J. bras. pneumol; 44 (6), 2018
ABSTRACT Objectives: To characterize the main identified mutations on cystic fibrosis transmembrane conductance regulator (CFTR) in a group of children and adolescents at a cystic fibrosis center and its association with the clinical and laboratorial characteristics. Method: Descriptive cross-sectiona...

Progresos en farmacoterapia en fibrosis quística

Cystic fibrosis is an autosomal recessive multisystemic disease caused by a mutation in the gene encoding the CFTR protein (cystic fibrosis transmembrane conductance regulator). For decades treatments were focused on pulmonary and extrapulmonary symptoms, but in recent years new treatments based on genet...

Variants in the interleukin 8 gene and the response to inhaled bronchodilators in cystic fibrosis

J. pediatr. (Rio J.); 93 (6), 2017
Abstract Objective: Interleukin 8 protein promotes inflammatory responses, even in airways. The presence of interleukin 8 gene variants causes altered inflammatory responses and possibly varied responses to inhaled bronchodilators. Thus, this study analyzed the interleukin 8 variants (rs4073, rs2227306,...

Informe de evaluación científica basada en la evidencia disponible: fibrosis quística
Scientific evaluation report based on available evidence: cystic fibrosis

INTRODUCCIÓN: La fibrosis quística (FQ) es la enfermedad autosómica recesiva más frecuente entre las poblaciones caucásicas, con una frecuencia de 1 en 2000 a 3000 nacidos vivos. Esta patología es producida por la mutación del gen que codifica la proteína reguladora de la conductancia transmembra...